Tag archive for ‘Roth Capital Partners’
Gil Tanenbaum On Monday, November 17th, 2014

NeuroDerm’s IPO Comes Up Short

– Israel’s NeuroDerm, which has developed a transdermal drug delivery system for the treatment of Parkinson’s disease, held a less than stellar IPO on the NASDAQ, selling 4.5 million shares More...

Gil Tanenbaum On Monday, November 3rd, 2014

Pharmaceutical NeuroDerm Prepares for NASDAQ IPO

NeuroDerm Ltd., an Israeli clinical stage pharmaceutical company which develops drugs for central nervous system (CNS) diseases, announced the launch of its initial public offering of 4.5 million ordinary More...

Wordpress site Developed by Fixing WordPress Problems